Global Ovarian Cancer Market 2014-2018

Global Ovarian Cancer Market 2014-2018

Category : Healthcare
Published On : June  2014
Pages : 45

------------ Or -------------

About Ovarian Cancer and its therapy
Ovarian cancer is a condition where a malignancy forms in the ovarian tissue and is caused by uncontrollable cell growth. It is one of the major gynaecological cancers worldwide and a leading cause of death. Ovarian cancer is difficult to diagnose in the initial stages because the symptoms are similar to that of gastric disorders like bloating, abdominal discomfort, difficulty in eating in the early stage and nausea, vomiting, constipation and diarrhoea in the later stages. It is often diagnosed in advanced stages when the metastasis has set in because the diagnostic techniques are not well-developed. Ovarian cancer can be treated by using chemotherapy, targeted therapy, and surgery. Although the market has a limited number of drugs for the treatment of ovarian cancer currently, a strong product pipeline is in development for the forecast period.
TechNavio's analysts forecast the Global Ovarian Cancer market will grow at a CAGR of 13.85 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Ovarian Cancer market for the period 2013–2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of ovarian cancer that are available in the market.
TechNavio's report, the Global Ovarian Cancer Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Ovarian Cancer market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas 
• EMEA        
Key Vendors
• Bristol Myers Squibb Company
• Eli Lilly and Company
• GlaxoSmithKline plc
• Janssen Pharmaceuticals Inc.
• F. Hoffman-La Roche Ltd
Other Prominent Vendors
• Aprea AB
• Aetera Zenteris Inc.
• Amgen Inc.
• Astra Zeneca plc
• Bionumerik Pharmaceuticals Inc.
• Boehringer Ingelheim GmbH
• Genentech Inc.
• MEI Pharmaceuticals Inc.
• Nektar Therapeutics
• NeoPharm Inc.
• Novogen Inc.
• Oasmia Pharmaceuticals AB
• Synta Pharmaceuticals Corp.
Key Market Driver
• Promising Drug Pipeline.
• For a full, detailed list, view our report.
Key Market Challenge
• Lack of Accurate Diagnosis of Ovarian Cancer.
• For a full, detailed list, view our report.
Key Market Trend
• Increase in the Funding Activities.
• For a full, detailed list, view our report.
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.



01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

Product Profiles

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Rate of Incidence and Prevalence

08. Market Segmentation by Type of Therapy

08.1.1 Chemotherapy

08.1.2 Targeted Therapy

09. Pipeline Portfolio

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

18.1 Competitive Scenario

18.1.1 Key News

18.1.2 Mergers and Acquisitions

18.2 Market Share Analysis 2013

18.3 Other Prominent Vendors

19. Key Vendor Analysis

20. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global Ovarian Cancer Market 2013-2018 (US$ billion)

Exhibit 3: Global Ovarian Cancer Market 2013-2018 by Type of Therapy

Exhibit 4: Snapshot of Ovarian Cancer Pipeline 2013

Exhibit 5: Global Ovarian Cancer Market by Geographical Segmentation 2013


Enquiry Before Buy